Managing Psoriatic Diseases: A Multi-disciplinary overview

Speciality: Dermatology


Speaker:

Dr. Sandeep Chauhan (Speaker) | (Rheumatologist) MD (Med.), FICP, MNAMS, FIACM Fellowship (Rhematology) ,UK CCST

Dr. Satbir Kaur (Speaker) | (Rheumatologist) MBBS, DNB (Med.) Consultant Rhematologist & Medical Specialist

Dr. Vikram Lahoria (Speaker) | (Dermatologist) MBBS, MD, Consultant Dermatologist

Description:

A warm welcome to all the medical professionals in this interesting session on Managing Psoriatic Diseases: A Multi-disciplinary overview
Managing psoriatic diseases, including psoriasis and psoriatic arthritis, requires a multidisciplinary approach due to the complex and multifaceted nature of these conditions. The involvement of various medical specialties—such as dermatology, rheumatology, and sometimes gastroenterology and cardiology—is crucial to addressing the diverse symptoms and potential comorbidities associated with psoriatic diseases. Dermatologists focus on managing skin symptoms, using treatments like topical therapies, phototherapy, and systemic medications, including biologics that target specific immune pathways.
Rheumatologists play a key role in managing psoriatic arthritis, a condition that can lead to joint pain, stiffness, and irreversible damage if left untreated. They often prescribe DMARDs (disease-modifying antirheumatic drugs) or biologics to control joint inflammation and prevent progression. Coordination between dermatologists and rheumatologists ensures that both skin and joint symptoms are addressed simultaneously, providing comprehensive care that improves patient outcomes.
Therefore, get an overall knowledge of Managing Psoriatic Diseases: A Multi-disciplinary overview
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

4.

The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.

5.

Virtual Reality Travel Reduces Cancer Pain.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot